The discovery of a new critical enzyme could help engineer climate resilient crops capable of sucking far more carbon dioxide from the atmosphere in a much more efficient way.
Researchers have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global fight against the disease.
A low-cost, non-toxic cancer treatment has been developed by researchers at The Australian National University (ANU). The treatment uses dead bacteria to help kick-start the immune system and shrink cancer.
Researchers from The Australian National University (ANU) have exposed a fatal flaw in the deadly parasite that causes malaria - one of the world's biggest killers.
DNA stability is a prerequisite in many of its applications, ranging from DNA-based vaccine, data storage to gene therapy. However, the existing strategies to enhance the DNA stability are ineffective and limited in scope.
Synthetic chemistry and synthetic biology offer complementary tools for manipulating the 3D architecture and function of biomolecules. I will outline two different projects that exemplify our hybrid chemical biology approach, highlighting divergent applications in catalysis and cancer therapy.
Associate Professor Kelly Roger's team has built a lattice light sheet microscope which was instrumental in the discovery that mitochondrial DNA is released during apoptosis through BAK and BAX pores in the outer mitochondrial membrane.
Malaria is a major global health problem, with 247 million cases and 619,000 deaths estimated in 2021. Antimalarial drugs are critical for malaria treatment and eradication efforts.
Malaria is a devastating disease caused by the Plasmodium parasite. Due to the threat of emerging drug resistance, the current arsenal of clinically used artemisinin combination therapies and drug candidates undergoing clinical assessment may not be sufficient in eliminating the disease.